Low-Cost Virtual Therapeutics and Digital Biomarkers for the Early Assessment and Personalized Treatment of Mild Cognitive Impairment
Mild Cognitive Impairment (MCI) is a term used to describe the transitional stage that occurs between normal aging and the onset of dementia. Spatial disorientation is often considered a significant indicator for diagnosing dementia. Numerous studies have documented deficits in both the allocentric and egocentric spatial frames of reference, as well as difficulties in transitioning between them, in individuals with MCI. Rapid advances in computing technology have enabled researchers to conduct cognitive training and rehabilitation interventions with the assistance of technology. Therefore, the aim of the study is to use virtual therapeutics to train MCI spatial memory.
• a change in cognition recognized by patients or observers (Caregiver/examiner)
• an objective impairment in one or more cognitive domains using traditional neuropsychological tests;
• autonomy or slight dependence on daily life activities;
• absence of diagnosis of dementia
• absence of cognitive impairment measured by the mini-mental state examination;
• aged 65 or over